Search - tctmd.com

Displaying 461 - 480 of 3032

Sort: Relevancy | Date

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Access to DCB Therapy for US Coronary Patients: FDA Perspective

Presenter: Adrian Magee

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Wearable HF Monitoring Devices: Landscape Overview, Patient Indications, and Implementation Science

Presenter: Liviu Klein

October 25, 2023

Presentation TCT 2023

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: Navin Kapur

October 25, 2023

Presentation TCT 2023

Acute Decompensated HF Trials: Who Should be Enrolled and What Should the Study Endpoints Be?

Presenter: JoAnn Lindenfeld

October 25, 2023

Presentation TCT 2023

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

Presenter: Jonathan Paul

October 25, 2023

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

Presentation TCT 2023

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

Presenter: Mehdi Shishehbor

October 25, 2023

Presentation TCT 2023

PROs are a Powerful Endpoint in TR Interventional Trials

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Presentation TCT 2023

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Presenter: Gabor Toth

October 25, 2023

Presentation TCT 2023

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Presenter: Juan Granada

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

Summary

Presenter: Vinayak Bapat

October 25, 2023

Presentation TCT 2023

Coronary Risk Mitigation

Presenter: Jaffar Khan

October 25, 2023

Presentation TCT 2023

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2023

Additional Case-Based Analysis and Procedure Examples

Presenter: Atsushi Okada

October 25, 2023

Advertisement

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Access to DCB Therapy for US Coronary Patients: FDA Perspective

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Wearable HF Monitoring Devices: Landscape Overview, Patient Indications, and Implementation Science

The Conundrum of Clinical Trials in Cardiogenic Shock

Acute Decompensated HF Trials: Who Should be Enrolled and What Should the Study Endpoints Be?

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

PROs are a Powerful Endpoint in TR Interventional Trials

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Summary

Coronary Risk Mitigation

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Additional Case-Based Analysis and Procedure Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content